Metformin as a promising therapeutic option for reducing substance withdrawal syndromes: A narrative review
- DOI
- 10.1016/j.biopha.2026.119553
- Published
- 2026-07
- Container
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.biopha.2026.119553,
title = {Metformin as a promising therapeutic option for reducing substance withdrawal syndromes: A narrative review},
author = {Soha Azadi and Maysam Fadaei-Kenarsary and Keivan Sahebi and Maryam Baneshi and Amir Tajbakhsh and Hossein Niknahad and Manica Negahdaripour},
year = {2026},
journal = {Biomedicine \& Pharmacotherapy},
doi = {10.1016/j.biopha.2026.119553},
url = {https://doi.org/10.1016/j.biopha.2026.119553}
}RIS
TY - JOUR TI - Metformin as a promising therapeutic option for reducing substance withdrawal syndromes: A narrative review AU - Soha Azadi AU - Maysam Fadaei-Kenarsary AU - Keivan Sahebi AU - Maryam Baneshi AU - Amir Tajbakhsh AU - Hossein Niknahad AU - Manica Negahdaripour PY - 2026 JO - Biomedicine & Pharmacotherapy DO - 10.1016/j.biopha.2026.119553 UR - https://doi.org/10.1016/j.biopha.2026.119553 ER -
APA
Azadi, S., Fadaei-Kenarsary, M., Sahebi, K., Baneshi, M., Tajbakhsh, A., Niknahad, H., & Negahdaripour, M. (2026). Metformin as a promising therapeutic option for reducing substance withdrawal syndromes: A narrative review. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2026.119553
Source records
- crossref · retrieved 2026-09-25T22:54:07.068Z